TCIM
SGYP

TIAA CREF Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

TIAA CREF Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-516,300
Closed -$878K – 3045
2018
Q3 		$878K Sell
516,300
-16,639
-3% -$29.8K ﹤0.01% 2483
2018
Q2 		$927K Sell
532,939
-29,795
-5% -$51.5K ﹤0.01% 2524
2018
Q1 		$1.03M Sell
562,734
-34,486
-6% -$72.8K ﹤0.01% 2429
2017
Q4 		$1.33M Sell
597,220
-636,636
-52% -$1.58M ﹤0.01% 2328
2017
Q3 		$3.58M Buy
1,233,856
+622,035
+102% +$2.12M ﹤0.01% 1831
2017
Q2 		$2.72M Sell
611,821
-226,225
-27% -$933K ﹤0.01% 1987
2017
Q1 		$3.9M Buy
838,046
+113,591
+16% +$659K ﹤0.01% 1743
2016
Q4 		$4.41M Sell
724,455
-313,112
-30% -$1.64M ﹤0.01% 1681
2016
Q3 		$1.04M Sell
1,037,567
-9,379
-0.9% -$43.9K 0.65% 26
2016
Q2 		$3.98M Buy
1,046,946
+733,145
+234% +$2.48M ﹤0.01% 1711
2016
Q1 		$866K Sell
313,801
-38,410
-11% -$139K ﹤0.01% 2554
2015
Q4 		$2M Sell
352,211
-40,755
-10% -$248K ﹤0.01% 2154
2015
Q3 		$2.08M Buy
392,966
+52,470
+15% +$406K ﹤0.01% 2113
2015
Q2 		$2.83M Sell
340,496
-12,939
-4% -$62.7K ﹤0.01% 2076
2015
Q1 		$1.63M Buy
353,435
+12,935
+4% +$42.1K ﹤0.01% 2346
2014
Q4 		$1.04M Buy
340,500
+11,186
+3% +$33.1K ﹤0.01% 2629
2014
Q3 		$917K Sell
329,314
-9,376
-3% -$34K ﹤0.01% 2680
2014
Q2 		$1.38M Buy
338,690
+26,095
+8% +$111K ﹤0.01% 2526
2014
Q1 		$1.66M Sell
312,595
-10,481
-3% -$58.8K ﹤0.01% 2349
2013
Q4 		$1.79M Sell
323,076
-63,739
-16% -$275K ﹤0.01% 2318
2013
Q3 		$1.74M Sell
386,815
-29,834
-7% -$134K ﹤0.01% 2301
2013
Q2 		$1.77M Buy
+416,649
New +$2.09M ﹤0.01% 2244

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TIAA CREF Investment Management's SGYP Position: Q4 2018 in Review

TIAA CREF Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 516,300 shares — an estimated $878K sold.

TIAA CREF Investment Management first reported a position in SGYP in Q2 2013 and held it in 22 quarters. The position peaked at $4.41M in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • TIAA CREF Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 516,300 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $878K.
  • TIAA CREF Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 22 quarters.
  • TIAA CREF Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.41M in Q4 2016.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on TIAA CREF Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.